IBEX Limited (NASDAQ:IBEX – Get Free Report) insider Bruce Dawson sold 4,050 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $50.65, for a total value of $205,132.50. Following the completion of the sale, the insider owned 67,873 shares of the company’s stock, valued at approximately $3,437,767.45. This trade represents a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
IBEX Stock Up 3.9%
Shares of IBEX stock opened at $52.23 on Wednesday. IBEX Limited has a 12 month low of $25.94 and a 12 month high of $52.29. The business’s 50 day moving average is $43.52 and its two-hundred day moving average is $34.63. The company has a market cap of $696.23 million, a PE ratio of 15.83 and a beta of 0.74.
IBEX (NASDAQ:IBEX – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.20. IBEX had a net margin of 7.34% and a return on equity of 29.10%. The company had revenue of $175.23 million for the quarter, compared to analyst estimates of $169.31 million.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the stock. Royal Bank Of Canada boosted their target price on shares of IBEX from $40.00 to $45.00 and gave the stock a “sector perform” rating in a research report on Tuesday. Robert W. Baird raised their price target on IBEX from $40.00 to $44.00 and gave the company a “neutral” rating in a research report on Monday, September 28th. Wall Street Zen upgraded IBEX from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Finally, Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, October 12th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, IBEX presently has a consensus rating of “Hold” and an average target price of $44.50.
View Our Latest Stock Analysis on IBEX
Institutional Investors Weigh In On IBEX
Hedge funds have recently modified their holdings of the business. Boston Partners grew its stake in shares of IBEX by 15.3% in the third quarter. Boston Partners now owns 397,353 shares of the company’s stock worth $17,189,000 after acquiring an additional 52,638 shares during the last quarter. Dimensional Fund Advisors LP increased its position in IBEX by 7.5% during the first quarter. Dimensional Fund Advisors LP now owns 358,191 shares of the company’s stock worth $9,607,000 after acquiring an additional 24,942 shares during the period. Tieton Capital Management LLC bought a new position in IBEX during the second quarter worth $8,353,000. Hillsdale Investment Management Inc. raised its stake in IBEX by 2.8% during the 1st quarter. Hillsdale Investment Management Inc. now owns 264,200 shares of the company’s stock valued at $7,086,000 after purchasing an additional 7,300 shares during the last quarter. Finally, Pinnacle Associates Ltd. raised its stake in IBEX by 3.4% during the 3rd quarter. Pinnacle Associates Ltd. now owns 208,027 shares of the company’s stock valued at $8,999,000 after purchasing an additional 6,932 shares during the last quarter. 81.24% of the stock is owned by institutional investors.
Trending Headlines about IBEX
Here are the key news stories impacting IBEX this week:
- Positive Sentiment: IBEX CEO Bob Dechant and CFO Taylor Greenwald are scheduled to present at the RBC 2026 Global TIMT Conference on November 17. The event offers an opportunity to discuss the business and its outlook, though no new financial guidance was announced. Conference announcement
- Neutral Sentiment: A short-interest report lists zero shares sold short as of November 10, despite characterizing short interest as having increased. If the zero figure is accurate, it indicates little reported short positioning; the conflicting description makes the update difficult to interpret.
- Negative Sentiment: RBC raised its price target to $45 from $40 but maintained a “sector perform” rating. The new target is below the recent share price, implying potential downside and suggesting the analyst sees limited near-term upside at current levels.
- Negative Sentiment: Six IBEX insiders, including CEO Dechant, reported share sales totaling about 31,200 shares. Dechant’s 5,000-share transaction was made under a pre-arranged Rule 10b5-1 plan, and sellers retained shares after their trades; nonetheless, the cluster of sales could weigh on sentiment. CEO filing Insider filing Insider filing Insider filing Insider filing Director filing
IBEX Company Profile
IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services. The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.
Recommended Stories
- Five stocks we like better than IBEX
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
